News

The Tri-Institutional Therapeutics Discovery Institute, a partnership between Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine and Takeda, joins with Deerfield Management and Bay City Capital to create an accelerated path to innovative therapies to treat disease.

Individual proteins coalesce to create an intricate network. When intact, that network protects certain cancers...

Dr. Leonard N. Girardi, O. Wayne Isom Professor of Cardiothoracic Surgery and chairman and...

Benefactors Ellen and Gary Davis have generously made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.

Researchers from the Meinig School of Biomedical Engineering and Weill Cornell Medicine are teaming up to learn more about antibiotic resistance in patients with low levels of infection-fighting white blood cells, such as those with leukemia.

Dr. Eftychia Apostolou, an assistant professor of molecular biology in medicine at Weill Cornell Medicine, has won a New Innovator Award from the National Institutes of Health for her research on how cells preserve their identity under normal conditions or alter it during pathogenesis, such as cancer.

Awards, honors, prizes and achievements for the week of Oct. 14 - Oct. 21.

For nephrologist Dr. Phyllis August, helping women with kidney disorders or high-blood pressure become pregnant is as much her passion as it is part of her identity as a doctor.

Dr. Zoltan Antal has been named chief of pediatric endocrinology at the Phyllis and David Komansky Center for Children's Health at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Aug. 1.

Study provides a framework for understanding the biological basis for chemotherapy resistance in bladder cancer.

Drs. Francis Lee and Jane Salmon are among 70 new members and nine foreign associations announced this year at NAM's 46th annual meeting on Oct. 17 in Washington, D.C.

Awards, honors, prizes and achievements for the week of Oct. 7 - 14.

NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Medical Center and the FDNY, is launching the Mobile Stroke Treatment Unit, the first of its kind on the East Coast.

An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease.

Led by researchers from NewYork-Presbyterian and Weill Cornell Medicine, the new study published in the annals of surgical oncology finds that cryoablation is a viable treatment for some breast cancers

Through the Healthcare Leadership and Management Scholars Program, medical students learned about hospital administration and finance, clinical quality and patient safety, policy making and clinical operations management.

Adam Johnson will research cardiovascular complications in patients with a genetic connective tissue disorder called Marfan syndrome.

Awards, honors, prizes and achievements for the week of Sept. 30 - Oct. 7.

Weill Cornell Medicine Researcher Selected For Eli Lilly Externship Program

Awards, honors, prizes and achievements for the week of Sept. 23 - Sept. 30.